Sunday, September 30, 2018

Status and Update of this Blog, September 30, 2018

Since this blog started on 9/7/2015, this blog has been viewed for 14,641 times by people around the world.

The first five countries are Israel (8,762), United States (2,796), Ireland (589), Russia (547), and Germany (546). The other viewers were from Ukraine, Brazil, United Kingdom, Japan, Spain, France, Cyprus,  Hong Kong, Canada, Italy, Thailand, Philippines, India, Malaysia, Mexico, Singapore, Chile, Argentina, Puerto Rico, Kenya, Brunel, etc. Isreal has moved up to the first place and United States of America has dropped to the second.

As to the browsers, 44% used Chrome, 29% used Firefox, 14% used Explorer, 8% used Safari, 1% used Opera, and the rest by all others. It is pretty clear that Chrome has been and is still the primary browser.

As to the operating systems, 44% used Windows, 18% used Linux, 14% used Android, 14% used Macintosh, and the rest by other systems. It is obvious that Windows is the most popular operating system.

One recent happening to share with you is that, as the principal investigator (PI), I have recently received another research grant from National Institutes of Health (NIH) of the United States to investigate a novel small molecule to reduce the side effects incurred by total body irradiation. The news release can be found on the website of 21st Century Therapeutics, www.21-cti.com.

By the way, if you’d like to read more than just my blog, you can order my second book (SIDE EFFECTS OF CHEMOTHERAPY AND RADIOTHERAPY) from amazon.com. Meanwhile, please continue to read my blog and recommend it to your loved ones and friends.


Thank you for our visit.

© Jiajiu Shaw, 2018

Disclaimer: This blog is written solely for informational purposes. It does not constitute the practice of any medical, nursing or other medical professional health care advice, diagnosis, or treatment. All contents posted are extracted from the book, "SIDE EFFECTS OF CHEMOTHERAPY AND RADIOTHERAPY", prepared by Dr. Jiajiu Shaw, Dr. Frederick Valeriote, and Dr. Ben Chen. 

No comments:

Post a Comment